ILMN vs. AVTR, PKI, A, MTD, WAT, TECH, CRL, BRKR, BIO, and PACB
Should you be buying Illumina stock or one of its competitors? The main competitors of Illumina include Avantor (AVTR), Revvity (PKI), Agilent Technologies (A), Mettler-Toledo International (MTD), Waters (WAT), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Bio-Rad Laboratories (BIO), and Pacific Biosciences of California (PACB).
Illumina (NASDAQ:ILMN) and Avantor (NYSE:AVTR) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk.
Avantor has a net margin of 3.79% compared to Illumina's net margin of -28.71%. Avantor's return on equity of 13.01% beat Illumina's return on equity.
Illumina received 911 more outperform votes than Avantor when rated by MarketBeat users. Likewise, 65.63% of users gave Illumina an outperform vote while only 63.64% of users gave Avantor an outperform vote.
Illumina presently has a consensus target price of $161.24, indicating a potential upside of 41.81%. Avantor has a consensus target price of $26.71, indicating a potential upside of 11.26%. Given Illumina's higher possible upside, equities analysts clearly believe Illumina is more favorable than Avantor.
89.4% of Illumina shares are held by institutional investors. Comparatively, 95.1% of Avantor shares are held by institutional investors. 0.2% of Illumina shares are held by insiders. Comparatively, 1.5% of Avantor shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Illumina has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, Avantor has a beta of 1.35, suggesting that its share price is 35% more volatile than the S&P 500.
Avantor has higher revenue and earnings than Illumina. Illumina is trading at a lower price-to-earnings ratio than Avantor, indicating that it is currently the more affordable of the two stocks.
In the previous week, Illumina had 13 more articles in the media than Avantor. MarketBeat recorded 22 mentions for Illumina and 9 mentions for Avantor. Avantor's average media sentiment score of 1.21 beat Illumina's score of 0.39 indicating that Avantor is being referred to more favorably in the news media.
Summary
Avantor beats Illumina on 13 of the 18 factors compared between the two stocks.
Get Illumina News Delivered to You Automatically
Sign up to receive the latest news and ratings for ILMN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ILMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Illumina Competitors List
Related Companies and Tools
